|
ALDH7A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.81299996816176E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.173999977932E-09 |
| Normal-vs-Stage2 |
4.43359999824366E-08 |
| Normal-vs-Stage3 |
2.10299999999775E-05 |
| Normal-vs-Stage4 |
1.8721999994753E-07 |
| Stage1-vs-Stage2 |
5.164600E-01 |
| Stage1-vs-Stage3 |
6.225700E-02 |
| Stage1-vs-Stage4 |
7.286600E-01 |
| Stage2-vs-Stage3 |
2.232400E-01 |
| Stage2-vs-Stage4 |
4.432000E-01 |
| Stage3-vs-Stage4 |
1.770820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.92909998875513E-09 |
| Normal-vs-AfricanAmerican |
3.38829997392764E-09 |
| Normal-vs-Asian |
3.557500E-02 |
| Caucasian-vs-AfricanAmerican |
5.866400E-02 |
| Caucasian-vs-Asian |
5.893000E-01 |
| AfricanAmerican-vs-Asian |
8.165400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8787000278262E-09 |
| Normal-vs-Female |
2.26850000006884E-07 |
| Male-vs-Female |
8.045600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62090000310755E-08 |
| Normal-vs-Extreme_Weight |
1.83259996067164E-09 |
| Normal-vs-Obese |
1.78810000139862E-08 |
| Normal-vs-Extreme_Obese |
4.615400E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.837590E-01 |
| Normal_Weight-vs-Obese |
8.767400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.006800E-01 |
| Extreme_Weight-vs-Obese |
6.280100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.873800E-01 |
| Obese-vs-Extreme_Obese |
8.866400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.77789999284062E-09 |
| Normal-vs-Age(41-60Yrs) |
1.395299997764E-08 |
| Normal-vs-Age(61-80Yrs) |
7.69770003294923E-09 |
| Normal-vs-Age(81-100Yrs) |
2.68110000001265E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.412200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.834400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.105230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.320200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.689400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.279600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82619996902389E-09 |
| Normal-VS-Type2 PRCC |
1.47569999997543E-07 |
| Normal-VS-KIRP CIMP |
5.0657000816301E-10 |
| Normal-VS-Unclassified PRCC |
5.41459999059413E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.77322999999063E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.219600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.892800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.14959999999387E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.017330E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.986200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1438000031313E-08 |
| Normal-vs-N1 |
2.47440000045174E-07 |
| Normal-vs-N2 |
9.36170030385597E-11 |
| N0-vs-N1 |
7.375200E-01 |
| N0-vs-N2 |
6.758200E-04 |
| N1-vs-N2 |
1.081870E-03 |
|
|
